ArticleEClinicalMedicine2022

Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up.

Berik Khairullin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.